Several Voyager Therapeutics Insiders Sell Shares Sending Potential Negative Signal
Several Voyager Therapeutics Insiders Sell Shares Sending Potential Negative Signal
Voyager Therapeutics, Inc. (NASDAQ:VYGR) shareholders may have reason to be concerned, as several insiders sold their shares over the past year. When analyzing insider transactions, it is usually more valuable to know whether insiders are buying versus knowing if they are selling, as the latter sends an ambiguous message. However, when multiple insiders sell stock over a specific duration, shareholders should take notice as that could possibly be a red flag.
Voyager Therapeutics, Inc.（NASDAQ：voyager therapeutics）的股东可能有理由担心，因为过去一年中有几位内部人士出售了他们的股份。分析内部交易时，通常更有价值的是知道内部人员是买入还是卖出，因为后者发送了一个模糊的信息。但是，当多名内部人员在特定持续时间内出售股票时，股东应该注意到，因为那可能是一个红色旗帜。
Although we don't think shareholders should simply follow insider transactions, we do think it is perfectly logical to keep tabs on what insiders are doing.
虽然我们不认为股东应该简单地跟随内部交易，但我们认为监控内部人士的行动是很合理的。
The Last 12 Months Of Insider Transactions At Voyager Therapeutics
Voyager Therapeutics的最后12个月内部交易
The President, Alfred Sandrock, made the biggest insider sale in the last 12 months. That single transaction was for US$119k worth of shares at a price of US$9.86 each. We generally don't like to see insider selling, but the lower the sale price, the more it concerns us. The silver lining is that this sell-down took place above the latest price (US$7.79). So it may not tell us anything about how insiders feel about the current share price.
总裁Alfred Sandrock是过去12个月中最大的内部销售。那笔单独的交易价值为119,000美元，每股价值9.86美元。我们通常不喜欢看到内部人士出售股票，但是销售价格越低，就越使我们担忧。好的一面是这次减少发生在最新价格（7.79美元）之上。因此，它可能告诉我们关于内部人员对当前股价感受的信息。
In the last year Voyager Therapeutics insiders didn't buy any company stock. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. By clicking on the graph below, you can see the precise details of each insider transaction!
在过去一年中，Voyager Therapeutics的内部人员没有购买任何公司股票。您可以在下面看到以公司和个人为单位的内部交易的可视化描绘。通过单击下面的图表，您可以查看每个内部交易的详细信息！
For those who like to find hidden gems this free list of small cap companies with recent insider purchasing, could be just the ticket.
对于那些喜欢发现潜力股票的人，可以免费查看最新内部交易股票的小盘公司名单，这可能正是您要找的机会。
Voyager Therapeutics Insiders Are Selling The Stock
Voyager Therapeutics内部人员正在出售该股票
The last three months saw significant insider selling at Voyager Therapeutics. In total, insiders sold US$133k worth of shares in that time, and we didn't record any purchases whatsoever. Overall this makes us a bit cautious, but it's not the be all and end all.
过去三个月，Voyager Therapeutics的内部人员大量出售。总共，内部人员在此期间出售了价值133,000美元的股票，而我们没有记录任何购买。总的来说，这让我们有点谨慎，但这并不是全部。
Does Voyager Therapeutics Boast High Insider Ownership?
Voyager Therapeutics是否拥有高内部持股？
Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. We usually like to see fairly high levels of insider ownership. Based on our data, Voyager Therapeutics insiders have about 1.1% of the stock, worth approximately US$4.8m. We prefer to see high levels of insider ownership.
测试公司领导者和其他股东之间的对齐性的另一种方法是查看他们拥有的股票数量。通常情况下，我们希望看到相当高的内部持股水平。根据我们的数据，Voyager Therapeutics的内部人员持有约1.1％的股份，价值约480万美元。我们更喜欢看到高水平的内部所有权。
So What Does This Data Suggest About Voyager Therapeutics Insiders?
那么这些数据对Voyager Therapeutics内部人员意味着什么？
Insiders sold stock recently, but they haven't been buying. And even if we look at the last year, we didn't see any purchases. Insiders own relatively few shares in the company, and when you consider the sales, we're not particularly excited about the stock. So we're not rushing to buy, to say the least. While it's good to be aware of what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. At Simply Wall St, we've found that Voyager Therapeutics has 4 warning signs (1 can't be ignored!) that deserve your attention before going any further with your analysis.
内部人员最近出售了股票，但他们没有购买。即使我们看过去一年，我们也没有看到任何购买。内部人员在公司中拥有相对较少的股份，而考虑到销售情况，我们对该股票并不特别感兴趣。因此，我们不急于购买，至少可以说是这样。虽然了解内部所有权和交易的情况很重要，但在做出任何投资决策之前，我们还要考虑股票面临的风险。在Simply Wall St，我们发现Voyager Therapeutics存在4个警告信号（1个不能忽视！）需要您在进行任何进一步分析之前注意。
Of course Voyager Therapeutics may not be the best stock to buy. So you may wish to see this free collection of high quality companies.
当然，Voyager Therapeutics可能不是最好的股票购买选择。因此，您可能希望查看这些高质量公司的免费集合。
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.
对于本文而言，内部人是指向相关监管机构报告其交易的个人。我们目前仅考虑公开市场交易和直接利益的私人处置，但不包括衍生交易或间接利益。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对本文有反馈？关于内容有所顾虑？直接和我们联系。或者，发送电子邮件至editorial-team (at) simplywallst.com。
这篇文章是Simply Wall St的一般性文章。我们根据历史数据和分析师预测提供评论，只使用公正的方法论，我们的文章并不意味着提供任何金融建议。文章不构成买卖任何股票的建议，也不考虑您的目标或您的财务状况。我们的目标是带给您基本数据驱动的长期关注分析。请注意，我们的分析可能不考虑最新的价格敏感公司公告或定性材料。Simply Wall St没有任何股票头寸。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
对本文有反馈？关于内容有所顾虑？直接和我们联系。或者发送电子邮件至editorial-team@simplywallst.com。